Traditional clinical and pathological predictors such as ER, PR, HER2, histological grade, or Ki-67 cannot provide individualized treatment strategies for breast cancer and often cause overtreatment with chemotherapy (10). This evidence concerns the gene ESR1 and breast carcinoma.